Safety of L1-79 in Adolescent and Adult Males With Autism
Clinical trial NCT02947048 · COMPLETED
Trial details
- NCT number
- NCT02947048
- Sponsor
- Yamo Pharmaceuticals LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.